• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Research and Markets: North China Pharmaceutical Group - a State-Owned Corporation Has Total Assets of RMB 11 Billion

Posted on: Monday, 3 April 2006, 03:03 CDT

Research and Markets (http://www.researchandmarkets.com/reports/c35115) has announced the addition of North China Pharmaceutical: A Company Analysis to their offering.

The North China Pharmaceutical Group is the largest pharmaceutical production enterprise in China, producing over 300 products, including antibiotics, semi-synthetic antibiotics, vitamins, genetically engineered pharmaceuticals, agrochemicals and veterinary.

EXTRACT FROM INTRODUCTION

'The North China Pharmaceutical Group is a completely state-owned corporation, that has been transformed from the original North China Pharmaceutical Factory that was set-up in 1958. The company has become increasingly commercialised, and has developed total assets of RMB 11 billion, with a compliment of 18,000 staff.

The Group now comprises 27 affiliated companies, either wholly-owned by the Group, or with a controlling share-holding, key amongst these being the North China Pharmaceutical limited liability stock company, that has listed A shares on the Shanghai Stock Exchange. The Group also has 17 subsidiary companies with foreign investment or foreign co-operation.'

For more information visit http://www.researchandmarkets.com/reports/c35115

Source: Business Wire

More News in this Category